Cost‐effectiveness analysis of human papillomavirus vaccines for the prevention of cervical cancer in India

Arora, S; Tuffaha, Haitham

doi:10.1111/ajco.13962

Cited by 2 publications

(2 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although these guidelines can improve cervical cancer detection and prevention, screening services can be costly, with costs varying widely due to screening under-use and inadequate use (3,(11)(12)(13)(14)(15). A previous study has identified an excess cost of $166,100 over 5 years for each ineligible woman (e.g., <21 and >65 years or those with a hysterectomy) who underwent screening (15).…”

Section: Introductionmentioning

confidence: 99%

Non-use and inadequate use of cervical cancer screening among a representative sample of women in the United States

Narcisse,

McElfish,

Hallgren

et al. 2024

Front. Public Health

View full text Add to dashboard Cite

IntroductionWomen's adherence to the United States (U.S.) Preventive Services Task Force guidelines for cervical cancer screening was determined by examining predisposing, enabling, and needs factors from Andersen's Behavioral Model of Health Services Use conceptual framework.MethodsThe outcome was operationalized as cervical cancer screening use, non-use, and inadequate-use. Multinomial logistic regression was conducted on data from the 2019 National Health Interview Survey of 7,331 eligible women aged 21–65.ResultsCompared with women who used cervical cancer screening services, women aged 30–65 were less likely to be Non-Users than those aged 21–29. Hispanic, Asian, and American Indian/Alaska Native (AIAN) women were more likely to be Non-Users than White women. More educated women were less likely to be Non-Users. Foreign-born women <10 years in the U.S. were more likely to be Non-Users than U.S.-born women. Women with financial hardship were less likely to be Non-Users. Poorer women and uninsured women were more likely to be Non-Users. Women with children in their household were less likely to be Non-Users than those without children. Women who had a well-visit in the past year were less likely to be Non-Users. Women with a history of human papillomavirus (HPV) vaccination were less likely to be Non-Users. Compared with women who used cervical cancer screening services, women aged 30–65 were less likely to be Inadequate-Users. AIAN women were more likely to be Inadequate-Users. Women of other races were less likely to be Inadequate-Users. Employed women were less likely to be Inadequate-Users. Uninsured women were more likely to be Inadequate-Users. Women who had a well-visit within a year were less likely to be Inadequate-Users. Women with past HPV vaccination were more likely to be Inadequate-Users. Smokers were less likely to be Inadequate-Users.DiscussionPredisposing, enabling, and needs factors are differently associated with non-use and inadequate use of cervical cancer screening. Understanding factors associated with the use, non-use, and inadequate use of cervical cancer screening is crucial to avoid or curb unnecessary tests, increased costs to both society and individuals, and the ill-allocation of limited resources.

show abstract

Section: Introductionmentioning

confidence: 99%

Non-use and inadequate use of cervical cancer screening among a representative sample of women in the United States

Narcisse,

McElfish,

Hallgren

et al. 2024

Front. Public Health

View full text Add to dashboard Cite

show abstract

“… 10 HPV vaccination has been described as cost-saving and cost-effective in reducing the incidence of cervical cancer and the consequences thereof in most of parts of the world. 11 - 13 It was estimated that vaccinating all 12-year-old females in the USA would protect annually more than 200,000 girls against HPV infections and 3300 against cervical cancer every year. 14 However, it must also not be forgotten that men are also a reservoir for HPV infection.…”

mentioning

confidence: 99%

Human Papilloma Virus Vaccines and Vaccination

Kara

2024

TAP

View full text Add to dashboard Cite

Cost‐effectiveness analysis of human papillomavirus vaccines for the prevention of cervical cancer in India

Cited by 2 publications

References 33 publications

Non-use and inadequate use of cervical cancer screening among a representative sample of women in the United States

Non-use and inadequate use of cervical cancer screening among a representative sample of women in the United States

Human Papilloma Virus Vaccines and Vaccination

Contact Info

Product

Resources

About